
Tobra-day™
Tobra-day contains tobramycin sulfate equivalent to 500 mg tobramycin base in water for injections to 5 mL. Sulfuric acid is added to adjust pH. Contains no preservatives.
For once daily intravenous use in the treatment of cystic fibrosis patients (>5 years old) with acute pulmonary exacerbations caused by susceptible organisms. This product may be put to uses other than that disclosed in the Product Information, which uses may be protected by patents.
500 mg in 5 mL
5 mL solution in 7 mL vial
10 vials
INJ093
Please log in to place an order
